Please use this identifier to cite or link to this item:
|Title:||The expression of calcitonin receptor detected in malignant cells of the brain tumour glioblastoma multiforme and functional properties in the cell line A172.|
|Authors:||Wookey, Peter J;McLean, Catriona A;Hwang, Peter;Furness, Sebastian G B;Nguyen, Sandy;Kourakis, Angela;Hare, David L;Rosenfeld, Jeffrey V|
|Affiliation:||Department of Medicine/Cardiology, University of Melbourne, Lance Townsend Building, Level 10, Austin Campus, Austin Health, Studley Road, Heidelberg, Vic. 3084, Australia. email@example.com|
|Citation:||Histopathology 2012; 60(6): 895-910|
|Abstract:||Previous studies have indicated that expression of calcitonin receptor (CTR) could be induced in a proinflammatory environment. In the present study, CTR-immunoreactivity (CTR-ir) was investigated in brain tissue from patients with glioblastoma multiforme (GBM).In immunohistochemical analysis of GBM samples, tissues with complex glomeruloid structures surrounded by malignant cells were analysed for CTR-ir using anti-human CTR antibodies generated against two separate epitopes of CTR. CTR-ir was associated predominantly with glial cells. Regions with CTR-ir cells were found in 12 of 14 GBM tumours (P < 0.05). Using confocal microscopy, CTR-ir cells were identified that were also positive for glial fibrillary acidic protein, nestin and CD133. Antibodies were verified using immunoblots and confocal microscopy of the Cercopithecus aethiops(COS)-7 transfectants. Immunoblots of membrane preparations from the CTR-positive cell lines demonstrated a major band (≈ 67 kDa) and minor band (≈ 52 kDa), but the intensity was reversed for the GBM cell line A172. In cultured A172 cells, functional studies demonstrated calcitonin stimulation of adenylyl cyclase and inhibition of extracellular-regulated kinase (ERK)1/2 phosphorylation.The findings that (i) CTR was expressed by glioma cells in a majority of GBM tumours tested, (ii) CTR(+) /CD133(+) cells were identified and (iii) second messenger systems were functionally modified by calcitonin in A172 cells suggest that CTR might be a useful therapeutic target in GBM.|
|Internal ID Number:||22335784|
Brain Neoplasms.drug therapy.metabolism.pathology
Cell Line, Tumor
MAP Kinase Signaling System
Second Messenger Systems
Tumor Markers, Biological.metabolism
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.